Series B
Education company Minerva Project has raised $70 million in a Series B round led by TAL Education Group, with participation from ZhenFund, Yonglin Group and Benchmark. The university focuses on global leadership and innovation and is accepting a class of 29 students this year at its San Francisco base. The new funds will be used to boost enrolment and expand the curriculum. “We have achieved every milestone we set out for Minerva to date: defined and built the curriculum, developed the Active Learning Forum, created the student experience, partnered with KGI and secured WASC approval for accredited degrees, hired an Ivy League caliber faculty, and recruited some of the most talented students on the planet to join our Founding Class. Now we are looking to scale and our Series B funding will allow us to do just that,” said Ben Nelson, founder, chairman and CEO of Minerva Project.
DNAtrix, an oncolytic immunotherapy company, has completed a $20 million Series B funding round. Morningside Ventures led the round, and existing investors Mercury Fund Targeted Technology Fund and others also participated. “Securing this funding is a significant milestone that will enable us to advance our lead oncolytic virus product DNX-2401 into late stage clinical trials for glioblastoma” said Frank Tufaro Ph.D. president and chief executive officer of DNAtrix.”We have encouraging results from four completed and ongoing clinical studies and this over-subscribed funding round validates our data-driven clinical approach.”
Series D
Marketing technology company Thismoment has closed a $17.6 million Series D investment round led by Sierra Ventures, Trident Capital and UMC. The company will use the new funding to advance the development of its user generated content marketing platform. “Our mission is to help enterprises evolve their use of UGC beyond promotions and campaigns into always-on business applications that transform how they engage with their customers, employees and prospects,” said Vince Broady, Founder and CEO.
Funding
Welltok, a developer of a health optimization platform has raised $25 million in new funding from Bessemer Venture Partners. The Red Herring Top 100 award winning company’s platform enables health managers to offer members wellness solutions which are integrated with wearables and apps. Welltok has raised $73 million to date and plans to add another $12 million to this round before year’s end. “We are gaining great momentum in creating a new market category, and helping drive the industry’s seismic shift to get consumers more involved in optimizing their health status,” said Jeff Margolis, chairman and chief executive officer of Welltok.